Forsight Vision4 Report issue

For profit Phase 1 Phase 2
Founded: Menlo Park CA United States (2005)
Status: Acquired by Roche (2017)

Organization Overview

First Clinical Trial
2010
NCT01186432
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree